RB1 and neuroendocrine carcinoma: Wei et al. recently reported a genetic analysis of 11 NEN classified as NEC and found no TP53 or RB1 alterations in any of the tumors, although other genes in the p53 and RB pathways were mutated at 18% and 27%, respectively68.